Log In
BCIQ
Print this Print this
 

ATL1102, ISIS 107248 (formerly ATL/TV-1102)

Also known as: TV-1102

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionSecond-generation antisense oligonucleotide (ASO) targeting VLA-4 mRNA
Molecular Target Integrin alpha(4) (VLA-4 ) (CD49D) mRNA
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/23/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today